SKI Market

Indian Indices

Sensex

79,116.19 -1,122.66
( -1.40%)

Global Indices

Nasdaq

48,521.56 -404.23
(-0.83%)

Dow Jones

6,836.74 -65.88
(-0.95%)

Hang Seng

54,115.64 -2,163.41
(-3.84%)

Nikkei 225

10,568.52 84.39
(0.80%)

Forex

USD-INR

91.48 0.43
(0.47%)

EUR-INR

107.28 -0.27
(-0.25%)

GBP-INR

122.62 -0.09
(-0.07%)

JPY-INR

0.58 0.00
(-0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5573934

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

23.29

108057.06

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.62

Back

Madhav Infra Projects reports consolidated net loss of Rs 4.19 crore in the December 2025 quarter

Feb 14,2026

Net loss of Madhav Infra Projects reported to Rs 4.19 crore in the quarter ended December 2025 as against net profit of Rs 2.69 crore during the previous quarter ended December 2024. Sales declined 63.53% to Rs 53.70 crore in the quarter ended December 2025 as against Rs 147.26 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	53.70	147.26	-64
OPM %	8.73	10.28	-
PBDT	-0.33	8.17	PL
PBT	-3.66	3.58	PL
NP	-4.19	2.69	PL

79,116.19 -1,122.66 ( -1.40%)

48,521.56 -404.23 (-0.83%)

6,836.74 -65.88 (-0.95%)

54,115.64 -2,163.41 (-3.84%)

10,568.52 84.39 (0.80%)

91.48 0.43 (0.47%)

107.28 -0.27 (-0.25%)

122.62 -0.09 (-0.07%)

0.58 0.00 (-0.14%)